Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02129803 · ClinicalTrials.gov registry record · NA
Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02129803 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 24 participants.
The verdict
NCT02129803, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study is a single center, randomized pilot study to evaluate the clinical effectiveness of nasal high flow 20LPM humidification therapy in subjects with Cystic Fibrosis.
Interventions
- DEVICE High-Flow, 20 LPM (via Optiflow cannula)
- DEVICE Low FLow, 5 LPM (via Optiflow cannula)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-05 |
| Est. Completion | 2019-05-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02129803
The ClinicalTrials.gov registry entry for NCT02129803 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High-Flow, 20 LPM (via Optiflow cannula) is the first listed.
NCT02129803 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02129803 about?
NCT02129803 is a clinical study titled "Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis". This study is a single center, randomized pilot study to evaluate the clinical effectiveness of nasal high flow 20LPM humidification therapy in subjects with Cystic Fibrosis.
What is the current status of trial NCT02129803?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-05. Estimated completion is 2019-05-29.
What interventions are being tested in trial NCT02129803?
The interventions under investigation include: High-Flow, 20 LPM (via Optiflow cannula) (DEVICE), Low FLow, 5 LPM (via Optiflow cannula) (DEVICE).
Who is sponsoring clinical trial NCT02129803?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.